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Medullary thymic epithelial cells (mTECs) are spe-
cialized for inducing central immunological tolerance
to self-antigens. To accomplish this, mTECs must
adopt a mature phenotype characterized by expres-
sion of the autoimmune regulator Aire, which acti-
vates the transcription of numerous genes encoding
tissue-restricted self-antigens. The mechanisms that
control mature Aire+ mTEC development in the
postnatal thymus remain poorly understood. We
demonstrate here that, although either CD4+ or
CD8+ thymocytes are sufficient to sustain formation
of a well-defined medulla, expansion of the mature
mTEC population requires autoantigen-specific in-
teractions between positively selected CD4+ thymo-
cytes bearing autoreactive T cell receptor (TCR) and
mTECs displaying cognate self-peptide-MHC class II
complexes. These interactions also involve the en-
gagement of CD40 on mTECs by CD40L induced on
the positively selected CD4+ thymocytes. This anti-
gen-specific TCR-MHC class II-mediated crosstalk
between CD4+ thymocytes and mTECs defines
a unique checkpoint in thymic stromal development
that is pivotal for generating a mature mTEC popula-
tion competent for ensuring central T cell tolerance.
INTRODUCTION
The thymus is divided into two anatomical compartments, the
cortex and medulla, each containing specialized types of thymic
epithelial cells (TECs) (Gill et al., 2003). TECs provide the micro-
environment required for T cell development. Cortical TECs
(cTECs) regulate the expansion of T cell progenitors, develop-Iment of T cell-receptor (TCR)-bearing CD4+CD8+ double-
positive (DP) thymocytes, positive selection of DP thymocytes,
and differentiation into single-positive (SP) CD4+ or CD8+ thymo-
cytes. Medullary TECs (mTECs) are required for deletion of
autoreactive SP thymocytes and thus for establishing immuno-
logical tolerance to self-proteins (Takahama, 2006). mTECs are
pivotal for this negative selection process because they express
a wide range of peripheral tissue-restricted self-antigens (TRAs)
(Derbinski et al., 2001; Kyewski and Klein, 2006).
There are two main mTEC subsets, referred to as immature
and mature (Farr et al., 2002). Characteristic features of mature
mTECs include high expression of MHC class II (MHCII), costi-
mulatory molecules (CD80, CD86, CD40) and numerous
TRAs (Anderson et al., 2002; Gray et al., 2006). The latter is
regulated in part by the autoimmune regulator Aire, a transcrip-
tion factor that is defective in autoimmune polyendocrinopathy
candidiasis extrodermal dystrophy (APECED; also known as
autoimmune polyendocrinopathy syndrome 1 [APS1], MIM
#240300) (Anderson et al., 2002). Mature Aire+ mTECs have
been described to be short-lived nonproliferating cells that dif-
ferentiate from a proliferating pool of immature mTEC precursors
(Gray et al., 2007; Rossi et al., 2007).
Knowledge of the mechanisms that regulate mature mTEC de-
velopment remains fragmentary. RANKL-mediated signals pro-
vided by lymphoid tissue inducer (LTi) cells are believed to trigger
mature Aire+ mTEC development in the embryonic thymus
(Rossi et al., 2007). Other studies have established that T cell de-
velopment and TEC differentiation and organization are guided
by reciprocal interactions between the two cell types, a process
designated as ‘‘thymic crosstalk’’ (Gill et al., 2003; Hollander
et al., 1995; Rodewald, 2008; Shores et al., 1991; Surh et al.,
1992; van Ewijk et al., 2000). Development of the thymic medulla
has been reported to be controlled by TCR-bearing thymocytes
(Shores et al., 1991) or mature T cells (Surh et al., 1992). The
medullary size, composition, and organization are furthermore
severely perturbed in Tcra/ and Zap70/ mice, which exhibit
a block in thymocyte development at the DP stage (Negishi et al.,mmunity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc. 451
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Control of Mature mTEC Development by CD4+ T Cells1995; Palmer et al., 1993). These and other observations (Ander-
son et al., 1996) have demonstrated that positively selected SP
thymocytes promote formation of the medulla. However, the re-
spective contributions of CD4+ and CD8+ thymocytes to the or-
ganization of a functional medulla allowing the establishment of
central tolerance to self-antigens have not been defined. It has
also not been determined whether SP thymocytes control these
processes via physical interactions with mTEC and/or by the
release of soluble factors.
We show here that development of a normal number of mature
Aire+ mTECs in the postnatal thymus is governed by direct anti-
gen-specific TCR-MHCII-mediated interactions between autor-
eactive CD4+ thymocytes and mTECs displaying the cognate
autoantigen-MHCII complexes. This crosstalk involves engage-
ment of the CD40 receptor expressed on mTECs by its corre-
sponding ligand, CD40L, displayed by CD4+ thymocytes. These
results characterize a unique antigen-specific checkpoint in
thymic stromal development that is critical for the generation
of a mature mTEC population competent to ensure central
tolerance.
RESULTS
Mature mTEC Numbers Are Severely Reduced in Mice
Lacking CD4+ Thymocytes
To determine which SP thymocyte subset is implicated in forma-
tion of the medulla, we compared thymic sections from wild-type
(WT) mice, Tcra/ mice (which lack SP thymocytes), H2-Aa/
mice (which lack CD4+ thymocytes), and B2m/ mice (which
lack CD8+ thymocytes). Sections were stained with hematoxylin
and eosin or for the mTEC marker keratin 5 (Figure 1A). As re-
ported previously (Palmer et al., 1993), the thymi of Tcra/
mice contained only small mTEC clusters, confirming that forma-
tion of the medulla is dependent on SP thymocytes. In contrast,
medullary areas were well defined and normal in appearance in
both H2-Aa/ and B2m/ mice, indicating that formation of
the medulla can be sustained by either CD4+ or CD8+ thymo-
cytes.
Further staining of the thymic sections revealed a marked dif-
ference between H2-Aa/ and B2m/ mice in the number of
cells expressing the mTEC marker MTS10, the mature mTEC
marker bound by the UEA-1 lectin, and Aire (Figure 1B). Numbers
of MTS10+, UEA-1+, and Aire+ cells were substantially reduced in
H2-Aa/ mice but normal in B2m/ mice, suggesting that the
expansion of mature mTECs within the medulla is defective in
the absence of CD4+ thymocytes. To confirm this finding, we
quantified the absolute numbers of different mTEC subsets in
WT andH2-Aa/ mice by flow cytometry (Table S1 available on-
line). Total mTECs were defined as CD45Ly51EpCAM+ cells
(see Figure S1A). Mature mTEC subsets within the total
mTEC population were defined as Aire+, CD80hi, Aire+CD80hi,
and AireCD80hi cells (see Figure S1A). Immature mTEC were
defined as CD80 or lo cells (see Figure S1A). The absolute num-
bers per thymus of all mature mTEC subsets were substantially
reduced in H2-Aa/ mice (Table S1). Cell numbers were re-
duced to between 3% and 10% depending on the subset exam-
ined. The reduction was strongest for Aire+CD80hi mTECs.
Finally, a modest reduction in the absolute number of immature
CD80 or lo mTECs was also evident (Table S1).452 Immunity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc.We next quantified the percentage of total CD45Ly51
EpCAM+ mTECs that exhibit a mature phenotype based on
the expression of Aire and CD80. The percentages of Aire+,
CD80hi, Aire+CD80hi, and AireCD80hi mTECs were strongly
reduced in H2-Aa/ mice compared to WT and B2m/ mice
(Figure 1C, Figure S2A). Similar results were obtained when the
percentages of Aire+, CD80hi, Aire+CD80hi, AireCD80hi,
CD86+, and CD40+ mTECs were quantified in CD45Ly51 thy-
mic stromal cells (Figures S1B and S2B). Finally, the percentage
of immature CD80lo mTECs was reduced modestly but signifi-
cantly in the CD45Ly51 stromal cell population of H2-Aa/
mice (Figure 1D). Taken together, these results indicated that
CD4+ thymocytes are critical for the expansion of mature
mTEC cellularity and have a considerably less pronounced
influence on the number of immature mTECs.
To confirm the reduction in mature mTEC numbers inH2-Aa/
thymi, we quantified Aire and TRA mRNA expression by quanti-
tative RT-PCR (qRT-PCR). mRNA expression for Aire and Aire-
dependent TRAs (SP1, SP2, Insulin, MUP1) was significantly
reduced in H2-Aa/ mice (Figure 2A). The mRNA expression
for Casein b, an Aire-independent TRA, was also significantly
lower (Figure 2A), indicating that reduced TRA expression re-
flects lower mature mTEC numbers rather than the loss of Aire
gene activation.
CD4+ Thymocytes Promote mTEC Development
by Stimulating Their Proliferation
To study the mechanism responsible for the reduction in mature
mTEC numbers in H2-Aa/ mice, we quantified by flow cytom-
etry the fractions of CD45Ly51EpCAM+ mTECs that were pro-
liferating or undergoing apoptosis. TUNEL staining did not reveal
an increase in the frequency of apoptotic mTEC inH2-Aa/mice
(Figure 2B). In contrast, staining for Ki-67 expression revealed
marked reductions in the frequencies of proliferating total,
immature (CD80 or lo), and mature (CD80hi) mTECs (Figure 2C).
The mTEC deficiency in H2-Aa/ mice thus appeared to result
from reduced proliferation rather than increased apoptosis.
The ability of CD4+ thymocytes to promote mature mTEC de-
velopment was studied further by means of reaggregated thymic
organ culture (RTOC) experiments. Fetal thymic stromal cells
were reaggregated and cultured with purified DP or CD4+ thymo-
cytes. Only the CD4+ thymocytes induced a significant increase
in the number of Ly51I-A+ and Ly51I-A+CD80+ mTECs
(Figure 2D). Furthermore, only the CD4+ thymocytes induced
the expression of Aire, the Aire-dependent TRA insulin, and the
Aire-independent TRA casein b (Figure 2E). Positively selected
CD4+ thymocytes were thus able to induce the appearance of
mature mTECs in RTOC.
Functional Consequences of the Mature mTEC
Deficiency in H2-Aa/ Mice
Because TRA expression by mature mTEC is pivotal for inducing
negative selection of autoreactive thymocytes, including CD8+
thymocytes (Gallegos and Bevan, 2004), we explored whether
CD8+ T cell tolerance is affected in H2-Aa/ mice. Histological
examinations and flow-cytometry experiments revealed abnor-
mal infiltrations of the salivary glands, lungs, and intestine of
H2-Aa/ mice by activated CD69+ and CD44+ CD8+ T cells
(Figure S3 and data not shown). This infiltration would be
Immunity
Control of Mature mTEC Development by CD4+ T Cellsconsistent with a defect in central tolerance resulting from im-
paired negative selection of autoreactive CD8+ T cells induced
by the mature mTEC deficiency. Alternatively, it could be due
to the lack of natural regulatory T (Treg) cells or other CD4+
Treg cells. It should be mentioned, however, that adaptive Treg
cells are present (data not shown) and functional in MHCII-defi-
cient mice (Bochtler et al., 2006). Our results therefore suggest
Figure 1. Mature mTEC Development Is Se-
verely Impaired in Mice Lacking CD4+ Thy-
mocytes
(A) Thymic sections from WT, Tcra/, H2-Aa/,
and B2m/ mice were stained with hematoxylin
and eosin (HE) or antibodies against the mTEC-
specific marker keratin 5.
(B) Thymic sections from WT, H2-Aa/, and
B2m/ mice were stained for the expression of
MTS10, UEA-1, and Aire. c denotes cortex; m de-
notes medulla; the scale bar represents 100 mm.
Histograms show the means and standard devia-
tions for quantifications of fluorescence intensity
for MTS10 staining, and numbers of UEA-1+ and
Aire+ cells. Numbers of medullary areas analyzed
are indicated. Significance relative to WT: ***,
p < 0.001; **, p < 0.01; ns, not significant.
(C) Representative flow-cytometry profiles for the
expression of Aire, and both Aire and CD80, by
CD45Ly51EpCAM+ mTECs from WT, H2-Aa/,
and B2m/ mice. Numbers indicate the percent-
age of cells found in the indicated gates. Histo-
grams show the means and standard deviations
for quantifications of the percentage of Aire+,
Aire+CD80hi, and AireCD80hi mTECs. The
means, standard deviations, and numbers of
mice are indicated. Significance relative to WT:
**, p < 0.01; *, p < 0.05; ns, not significant.
(D) Representative flow-cytometry profiles for the
expression of CD80 by large CD45Ly51 thymic
stromal cells from WT, H2-Aa/, and B2m/
mice. Histograms show the means and standard
deviations for quantifications of the percentage
of CD80lo and CD80hi mTECs. The means, stan-
dard deviations, and numbers of mice are indi-
cated. Significance relative to WT: ***, p < 0.001;
ns, not significant.
that the mature mTEC deficiency ob-
served in H2-Aa/ mice contributes to
a loss of central tolerance in the CD8+
T cell population.
Mature mTEC Deficiency in Mice
Lacking CIITA Expression in TECs
To confirm the results obtained with
H2-Aa/ mice, we turned to two other
mouse models lacking positive selection
of CD4+ thymocytes. The latter were gen-
erated by introducing deletions in regula-
tory regions of the Ciita gene encoding
the MHCII transactivator CIITA. Three
cell-type-specific promoters (pI, pIII,
and pIV) control transcription of the Ciita
gene (Muhlethaler-Mottet et al., 1997; Reith et al., 2005). We
have generated mice lacking pIV (CiitaIV/IV mice) (Waldburger
et al., 2001) and both pIII and pIV (CiitaIII+IV/III+IV mice) (Lei-
bundGut-Landmann et al., 2004). Because pIV is essential for
CIITA expression in cTECs (Waldburger et al., 2003; Waldburger
et al., 2001), both CiitaIV/IV and CiitaIII+IV/III+IV mice lacked
MHCII expression on cTECs (Figure 3A). In contrast, thymicImmunity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc. 453
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Control of Mature mTEC Development by CD4+ T CellsFigure 2. mTEC Deficiency in Mice Lacking CD4+ Thymocytes
(A) The expression of mRNAs coding for Aire, Aire-induced TRAs (SP1, SP2, insulin, MUP1), and an Aire-independent TRA (casein b) was measured by qRT-PCR
in CD45 thymic stromal cells from WT and H2-Aa/ mice. Results are represented relative to WT and depict the means and standard deviations derived from
four experiments. Significance relative to WT: ***, p < 0.001; **, p < 0.01; *, p < 0.05.454 Immunity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc.
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Control of Mature mTEC Development by CD4+ T Cellsdendritic cells (DCs) and macrophages exhibited WT MHCII
expression in CiitaIV/IV and CiitaIII+IV/III+IV mice (Figure 3B)
because these cells rely on pI for driving Ciita expression
(LeibundGut-Landmann et al., 2004). The loss of MHCII expres-
sion by cTECs in CiitaIV/IV and CiitaIII+IV/III+IV mice led to
a block in positive selection of CD4+ thymocytes, such that the
numbers of CD4+ thymocytes and peripheral CD4+ T cells
were reduced as strongly as in H2-Aa/ mice (Figure S4). This
block in positive selection of CD4+ thymocytes resulted in an
mTEC deficiency identical to that observed in H2-Aa/ mice.
This was documented by three methods: quantification of the
percentage of CD45Ly51EpCAM+ mTECs exhibiting a mature
phenotype on the basis of Aire and CD80 expression (Figure 3C);
staining of thymic sections to visualize MTS10+, UEA-1+,
and Aire+ cells (Figure S5A); and quantification of the percentage
of mature Aire+ and CD80hi mTECs in CD45Ly51 stromal
cells (Figure S5B). The percentage of immature CD80lo cells in
the CD45Ly51 stromal cell population was also reduced mod-
estly (Figure S5B). The mTEC phenotype of CiitaIV/IV and
CiitaIII+IV/III+IV mice thus confirmed a key role of CD4+ thymo-
cytes in driving expansion of the mature mTEC compartment.
Furthermore, because DCs and macrophages retained MHCII
expression in CiitaIV/IV and CiitaIII+IV/III+IV mice, these results
indicated that the reduced mature mTEC cellularity observed in
H2-Aa/ mice was not simply due to a global loss of MHCII ex-
pression by all thymic cell types.
Mature mTEC Cellularity Is Controlled by MHCII-TCR
Mediated Interactions with CD4+ Thymocytes
In contrast to cTECs, mTECs rely on both pIII and pIV for driving
Ciita expression (unpublished data). The residual mature mTECs
consequently retained MHCII expression in CiitaIV/IV mice but
were MHCII negative in CiitaIII+IV/III+IV mice (Figure 3D). We
exploited this difference to determine whether mature mTEC
development requires physical TCR-MHCII-mediated interac-
tions between CD4+ thymocytes and mTECs. To address this
question, we introduced a CIITA transgene (Tg) (Figure S5C)
driven by a cTEC-specific promoter (Laufer et al., 1996) into
CiitaIV/IV and CiitaIII+IV/III+IV mice. This restored MHCII ex-
pression by cTECs (data not shown) and thus re-established
positive selection of CD4+ thymocytes (Figure 4).
The CD4+ thymocytes and peripheral CD4+ T cells that devel-
oped in Tg-CiitaIV/IV and Tg-CiitaIII+IV/III+IV mice were indis-
tinguishable from WT with respect to cell numbers and TCR
V-b repertoire (Figures 4). Positively selected CD4+ thymocytes
in Tg-CiitaIV/IV and Tg-CiitaIII+IV/III+IV mice also exhibited
a WT phenotype in that they upregulated TCR, CD3, and CD5
expression and exhibited normal proportions of semimatureImCD69hi and mature CD69lo cells (Figure 5A). Furthermore, they
activated expression of the chemokine receptor CCR7
(Figure 5B), which enables their migration into the medulla,
where its ligand, CCL21, is produced (Figure 5C) (Ueno et al.,
2004). Finally, CD4+ thymocytes in Tg-CiitaIV/IV and
Tg-CiitaIII+IV/III+IV mice expressed a WT pattern of genes en-
coding signaling molecules that have been implicated in promot-
ing mTEC maturation; they upregulated their expression of
CD40L, LTa, and RANKL mRNAs and expressed a normal
amount of LIGHT mRNA (Figure 5D). Taken together, these re-
sults indicated that the CD4+ thymocytes that develop in
Tg-CiitaIV/IV and Tg-CiitaIII+IV/III+IV mice are phenotypically
and functionally indistinguishable from those found in WT mice.
In contrast to cTECs, the Tg did not alter MHCII expression by
mTECs. MHCII expression by mTECs was unchanged in
Tg-CiitaIV/IV mice, whereas Tg-CiitaIII+IV/III+IV mTECs re-
mained MHCII negative (Figure 6A).
We next analyzed the composition of the mTEC populations in
Tg-CiitaIV/IV and Tg-CiitaIII+IV/III+IV mice. The fractions of to-
tal CD45Ly51EpCAM+ mTECs that exhibited mature Aire+,
Aire+CD80hi, and AireCD80hi phenotypes were restored to WT
in Tg-CiitaIV/IV mice (Figures 6B and 6C). In contrast, the num-
bers of mature mTECs in Tg-CiitaIII+IV/III+IV mice remained as
low as in CiitaIII+IV/III+IV and H2-Aa/ mice (Figures 6B and
6C). Furthermore, the percentage of immature CD80lo mTECs
present in total CD45Ly51 stromal cells was restored to the
WT level in Tg-CiitaIV/IV mice but remained reduced in
Tg-CiitaIII+IV/III+IV mice (Figure 6D). These findings were con-
firmed by calculation of the absolute numbers of immature and
mature mTEC subsets (data not shown). These results demon-
strated that direct MHCII-TCR-mediated interactions between
mTECs and CD4+ thymocytes are required for generating a
normal mature mTEC cellularity.
Mature mTEC Cellularity Is Controlled by Antigen-
Specific Interactions with CD4+ Thymocytes
To determine whether expansion of the mature-mTEC compart-
ment requires antigen-specific interactions with CD4+ thymo-
cytes, we analyzed the thymi of homozygous OTII mice—in
which most CD4+ T cells carry an MHCII-restricted TCR specific
for ovalbumin (OVA)—and of OTII mice carrying a RIPmOVA
transgene driving synthesis of membrane-bound OVA specifi-
cally in mTECs (Kurts et al., 1996) (Figure 7A). We also examined
the thymi of OTII and RIPmOVA-OTII mice on a Rag2/ back-
ground to eliminate leaky development of CD4+ thymocytes
expressing nontransgenic TCR (Figure 7B). In OTII and OTII-
Rag2/ thymi, the OVA-specific CD4+ thymocytes cannot en-
gage in antigen-specific interactions with mTECs and are not(B) The percentage of apoptotic TUNEL+ cells present in total CD45Ly51EpCAM+ mTECs from one WT and two H2-Aa/ mice was measured by flow cytom-
etry. The experiment was controlled with micrococcal nuclease (MN)-treated and untreated (UT) mTECs (left panel).
(C) The percentage of proliferating Ki-67+ cells present in total (CD45Ly51EpCAM+), immature (CD45Ly51EpCAM+CD80 or lo), and mature (CD45
Ly51EpCAM+CD80hi) mTECs from WT and H2-Aa/ mice was measured by flow cytometry. The isotype control is represented by a gray profile. Histograms
show the means and standard deviations derived from three independent experiments. For CD80hi mTECs from H2-Aa/ mice, two to five individual thymi were
pooled per experiment. Significance relative to WT: ***, p < 0.001; *, p < 0.05.
(D) dGUO-treated thymic stromal cells were reaggregated alone () or with equal numbers of DP or CD4+ thymocytes and cultured for 5 days. Cell numbers for the
indicated TEC populations were quantified by flow cytometry. The average and standard errors of three to four independent measurements are shown.
(E) The expression of mRNAs encoding Aire, insulin, and casein b was measured by qRT-PCR. Expression was expressed relative to those found in mature
mTECs purified from adult thymi. The average and standard errors of three to four independent measurements are shown.munity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc. 455
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with a significant reduction in the numbers of mature Aire+ and
CD80hi mTECs (Figure 7). In RIPmOVA-OTII and RIPmOVA-
OTII-Rag2/ mice, on the other hand, the OVA-specific CD4+
thymocytes can recognize OVA-MHCII complexes on mTECs
and are deleted by negative selection (data not shown) (Ander-
Figure 3. CiitaIV/IV and CiitaIII+IV/III+IV Mice Ex-
hibit a Marked Reduction in the Number of Mature
mTECs
(A) Thymic sections from WT, CiitaIV/IV, CiitaIII+IV/III+IV,
and H2-Aa/ mice were stained with an antibody against
I-Ab. c denotes cortex; m denotes medulla; the scale bar
represents 100 mm.
(B) I-Ab expression was analyzed by flow cytometry on
DCs and macrophages purified from the thymi of WT,
CiitaIV/IV, CiitaIII+IV/III+IV, and H2-Aa/ mice. The re-
sults are representative of at least three experiments.
The percentage of I-Ab+ cells is indicated.
(C) Representative flow-cytometry profiles of Aire and
CD80 expression by CD45Ly51EpCAM+ mTECs iso-
lated from WT, CiitaIV/IV, CiitaIII+IV/III+IV, and H2-Aa/
mice. Numbers indicate the percentage of cells found in
the indicated gates.
(D) I-Ab expression was analyzed by flow cytometry on
CD45Ly51CD80hi mTECs from WT, CiitaIV/IV,
CiitaIII+IV/III+IV, and H2-Aa/ mice. The percentage of
I-Ab+ cells is indicated. The results are representative of
at least three experiments for each genotype.
son et al., 2005). This led to the restoration of
a WT population of mature Aire+ and CD80hi
mTECs (Figure 7). Calculation of the absolute
numbers of these mature mTEC subsets con-
firmed these observations (Table S2). These re-
sults indicated that expansion of the mature
mTEC compartment is promoted by direct inter-
actions between the OVA-specific CD4+ thymo-
cytes and mTECs expressing the cognate
OVA-MHCII complexes.
The mature mTEC deficiency observed in
OTII-Rag2/ mice was as strong as in H2-
Aa/ mice. In contrast, the reduction in mature
mTEC numbers was less marked in homozy-
gous OTII mice. This mitigated reduction is
probably due to the residual development of
CD4+ thymocytes expressing nontransgenic
TCR. In OTII mice,3% of the CD4+ thymocytes
expressed nontransgenic TCR, whereas this
leaky development was completely abolished
in the OTII-Rag2/ mice (data not shown). Ma-
ture mTEC expansion can thus be sustained
even by very low numbers of polyclonal CD4+
thymocytes.
Staining of thymic sections with antibodies
against keratin 5 indicated that OTII-Rag2/
mice have well-defined medullary areas,
whereas only small clusters of keratin 5-positive
cells were observed in Rag2/ mice
(Figure 7D). Furthermore, absolute numbers of
CD45Ly51EpCAM+ mTECs were substantially larger in
OTII-Rag2/ mice than in Rag2/ mice (Figure 7D). This sug-
gests that OTII thymocytes can stimulate mTEC development
and sustain formation of the medulla in an antigen-independent
manner. However, the percentages of total mTECs that exhibited
mature Aire+ and CD80hi phenotypes were very similar between456 Immunity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc.
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Control of Mature mTEC Development by CD4+ T CellsFigure 4. Restoration of Positive Selection in Tg-CiitaIV/IV and Tg-CiitaIII+IV/III+IV Mice
(A) Thymic and lymph node T cells from WT,CiitaIV/IV, Tg-CiitaIV/IV,CiitaIII+IV/III+IV, Tg-CiitaIII+IV/III+IV, andH2-Aa/ mice were analyzed by flow cytometry
for the expression of CD4 and CD8. The percentage of CD4+ T cells is indicated.
(B) Histograms represent the percentage of CD4+ T cells in thymi and lymph nodes (LN) from WT, CiitaIV/IV, Tg-CiitaIV/IV, CiitaIII+IV/III+IV, Tg-CiitaIII+IV/III+IV,
and H2-Aa/ mice. The means and standard deviations derived from analysis of the indicated numbers of mice are shown. Significance relative to WT: ***,
p < 0.001.
(C) Histograms represent the TCRVb usage by thymic and lymph node (LN) CD4+ T cells from WT, Tg-CiitaIV/IV, and Tg-CiitaIII+IV/III+IV mice.OTII-Rag2/andRag2/mice, and these fractions were in both
cases as low as in H2-Aa/ mice (Figure 7C). This is consistent
with the interpretation that antigen-specific interactions with
CD4+ thymocytes are critical for driving a selective expansion
of the mature mTEC compartment within a well-defined medulla.
We next examined mature mTEC numbers in Marilyn-Rag2/
mice, which express an MHCII-restricted TCR recognizing the
male-specific H-Y antigen on a Rag2/ background. In Mari-
lyn-Rag2/ females, the H-Y-specific CD4+ thymocytes cannot
engage in antigen-specific interactions and were thus not elimi-
nated by negative selection (Figure S6A). This correlated with
a reduction in mature Aire+ and CD80hi mTEC numbers (Fig-
ure S6B). In contrast, the H-Y-specific CD4+ thymocytes were
eliminated by negative selection in Marilyn males (Figure S6A)
because the H-Y antigen is expressed in the male thymus. This
correlated with the restoration of a WT mature mTEC population
(Figure S6B). We confirmed by videomicroscopy experimentsImand in vitro activation assays that male but not female mTECs es-
tablished prolonged contacts with and activated H-Y-specific
CD4+ thymocytes (Figures S6C and S6D, Movies S1 and S2).
Taken together, these results suggested that expansion of the
mature mTEC compartment can be induced by prolonged H-
Y-specific interactions between the Marilyn CD4+ thymocytes
and the cognate H-Y-MHCII complexes displayed by male
mTECs.
Mature mTEC Expansion Involves the CD40L-CD40
Costimulatory Pathway
Several signaling pathways have been implicated in mTEC de-
velopment. Disruption of the lymphotoxin-b-receptor signaling
pathway at the level of its ligands (LTa1b2 or LIGHT3), the recep-
tor, or intracellular signaling molecules has been reported to
lead to a mature mTEC deficiency (Boehm et al., 2003; Burkly
et al., 1995; Derbinski and Kyewski, 2005; Kajiura et al., 2004;munity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc. 457
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Control of Mature mTEC Development by CD4+ T CellsKinoshita et al., 2006). Inactivation of TRAF6—an adaptor mol-
ecule required for signal transduction by CD40, RANK, and
other TNF family receptors—also leads to a mature mTEC defi-
ciency (Akiyama et al., 2005). Finally, mature mTEC develop-
ment is impaired in Tnfrsf11a/ mice (Rossi et al., 2007) as
well as in Tnfsf11/ and Tnfsf11/ Cd40/ mice (Akiyama
et al., 2008; Hikosaka et al., 2008; this issue of Immunity). To de-
termine whether these pathways might be implicated in the con-
trol of mature mTEC development by CD4+ thymocytes, we
compared the expression levels of CD40L, LTa, LTb, LIGHT,
and RANKL mRNAs between CD4+ and CD8+ thymocytes.
These mRNAs were all enriched in CD4+ thymocytes, but only
Figure 5. CD4+ Thymocytes in Tg-CiitaIV/IV and
Tg-CiitaIII+IV/III+IV Mice Display a WT Phenotype
and Migrate into the Medulla
(A) TCRab, CD33, CD5, and CD69 expression was ana-
lyzed by flow cytometry on DP and CD4+ thymocytes
from WT, Tg-CiitaIV/IV, and Tg-CiitaIII+IV/III+IV mice.
Mature (CD69lo) and semimature (CD69hi) CD4+ thymo-
cytes were identified on the basis of their expression level
of CD69. The percentages of CD69lo and CD69hi cells are
indicated.
(B) The expression of CCR7 mRNA was measured by qRT-
PCR in DP and CD4+ thymocytes from WT, Tg-CiitaIV/IV,
and Tg-CiitaIII+IV/III+IV mice.
(C) Thymic sections from WT, CiitaIV/IV, Tg-CiitaIV/IV,
CiitaIII+IV/III+IV, Tg-CiitaIII+IV/III+IV, and H2-Aa/ mice
were stained for CCL21 and CD4 expression. c denotes
cortex; m denotes medulla.
(D) The expression of CD40L, LTa, RANKL, and LIGHT
mRNAs was measured by qRT-PCR in DP and CD4+ thy-
mocytes from WT, Tg-CiitaIV/IV, and Tg-CiitaIII+IV/III+IV
mice.
CD40L mRNA was detected almost exclusively
in these cells (Figure S7A).
Cell-surface CD40L was undetectable on WT
thymocytes but readily observed on a fraction of
thymocytes in Cd40/ mice (Figure S7B). This
is reminiscent of the observation that CD40L is
downregulated on peripheral CD4+ T cells
upon engagement with CD40 (Lesley et al.,
2006). CD40L expression on Cd40/ thymo-
cytes was restricted to the CD4+ lineage
(Figure S7C) and was upregulated on thymo-
cytes having undergone positive selection
(Figure S7D). This expression pattern correlated
well with CD40L mRNA abundance in different
thymocyte subsets (Figure S7A). Finally,
CD40L expression was induced by positive se-
lection rather than by subsequent antigen-spe-
cific contacts with DCs or mTECs, because it
was upregulated in CD4+ OTII thymocytes irre-
spectively of whether or not the cognate OVA
antigen was expressed in the medulla
(Figure S7E). Similarly, CD40L expression was
also upregulated in CD4+ thymocytes irrespec-
tively of whether or not mTEC expressed MHCII
molecules (Figure 5B).
We next investigated the mTEC maturation status in Cd40/
and Cd40lg/ mice. Aire+, CD80hi, CD40+, and CD86+ mTEC
numbers were markedly reduced in both Cd40/ and
Cd40lg/ mice (Figure S8). The selective role of CD4+ thymo-
cytes in controlling mature mTEC development is thus mediated,
at least in part, by the interaction of CD40 on mTECs with CD40L
on CD4+ thymocytes. The mature mTEC deficiency in Cd40/
and Cd40lg/ mice was less severe than in H2-Aa/ mice, im-
plying that CD40L is likely to collaborate with other cell-surface
or soluble ligands produced by CD4+ thymocytes. These could
include LTa, LTb, LIGHT, and/or RANKL, which were all ex-
pressed preferentially by CD4+ thymocytes (Figures S7A and S9).458 Immunity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc.
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Control of Mature mTEC Development by CD4+ T CellsFigure 6. Mature mTEC Development Requires Direct MHCII-TCR-Mediated Interactions with CD4+ Thymocytes
(A) I-Ab expression was analyzed by flow cytometry on CD45Ly51CD80hi mTECs from WT,CiitaIV/IV, Tg-CiitaIV/IV,CiitaIII+IV/III+IV, Tg-CiitaIII+IV/III+IV, and
H2-Aa/ mice. The percentage of I-Ab+ cells is indicated. The results are representative of at least three experiments for each genotype.
(B) Representative flow-cytometry profiles showing the expression of Aire, and both Aire and CD80, by CD45Ly51EpCAM+ mTECs from WT, CiitaIV/IV,
Tg-CiitaIV/IV, CiitaIII+IV/III+IV, Tg-CiitaIII+IV/III+IV, and H2-Aa/ mice.
(C) Histograms represent the percentage of Aire+, Aire+CD80hi, and AireCD80hi mTECs present in total CD45Ly51EpCAM+ mTECs from WT, CiitaIV/IV,
Tg-CiitaIV/IV, CiitaIII+IV/III+IV, Tg-CiitaIII+IV/III+IV, and H2-Aa/ mice.
(D) Histograms represent the percentage of AireCD80lo mTECs present in large CD45Ly51 thymic stromal cells from WT, CiitaIV/IV, Tg-CiitaIV/IV,
CiitaIII+IV/III+IV, Tg-CiitaIII+IV/III+IV, and H2-Aa/ mice.
(C and D) The means, standard deviations, and numbers of mice are indicated. Significance relative to WT: ***, p < 0.001; **, p < 0.01; *, p < 0.05; ns, not significant.DISCUSSION
Previous work had demonstrated that positively selected thymo-
cytes are required for the formation of a correctly organized
medulla in the postnatal thymus. However, knowledge of the
mechanisms underlying the key influence of SP thymocytes onImthe generation of a functional medulla remained fragmentary.
In particular, these earlier studies did not define the respective
roles of CD4+ and CD8+ thymocytes in this process, or the role
of secreted factors versus direct physical contacts between
SP thymocytes and mTECs. In agreement with earlier studies ex-
amining the thymi of B2m- and MHCII-deficient mice (Nasreenmunity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc. 459
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Control of Mature mTEC Development by CD4+ T CellsFigure 7. Mature mTEC Development Requires Autoan-
tigen-Specific Interactions with CD4+ Thymocytes
(A) The percentage of Aire+ and CD80hi mTECs present in total
CD45Ly51 EpCAM+ mTECs from WT, OTII, RIPmOVA-OTII,
and H2-Aa/ mice was measured by flow cytometry.
(B) The percentage of Aire+ and CD80hi mTECs present in total
CD45Ly51EpCAM+ mTECs from WT, OTII-Rag2/, RIP-
mOVA-OTII-Rag2/, and H2-Aa/ mice was measured by
flow cytometry.
(C) Histograms summarize the percentage of Aire+ and CD80hi
mTECs present in CD45Ly51EpCAM+ mTECs from WT,
OTII, RIPmOVA-OTII, OTII-Rag2/, RIPmOVA-OTII-Rag2/,
Rag2/, and H2-Aa/ mice. The means, standard deviations,
and numbers of mice are indicated. Significance relative to
WT: ***, p < 0.001; **, p < 0.01; *, p < 0.05; ns, not significant.
(D) Thymic sections from Rag2/ and OTII-Rag2/ mice were
stained with antibodies against the mTEC marker keratin 5.
Two representative sections are shown for each genotype. Abso-
lute numbers of total CD45Ly51EpCAM+ mTECs are indicated
below. The means and standard deviations derived from three
mice are shown (p = 0.0265).460 Immunity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc.
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Control of Mature mTEC Development by CD4+ T Cellset al., 2003), we found that the formation of a well-defined me-
dulla can be sustained by either CD4+ or CD8+ thymocytes.
However, we discovered that CD4+ thymocytes play an addi-
tional crucial role in promoting expansion of the mature mTEC
compartment within the medulla. The latter function could not
be ensured efficiently by CD8+ thymocytes. Furthermore, we
found that the pivotal role of CD4+ thymocytes in promoting ma-
ture mTEC expansion was mediated by direct antigen-specific
interactions between CD4+ thymocytes bearing autoantigen-
specific TCR and mTECs displaying the cognate self-antigen-
MHCII complexes. Taken together, these results indicate that
two distinct processes exhibiting a differential dependence on
CD4+ and CD8+ thymocytes are involved in generating a func-
tional medulla. The first process, formation of the medulla, re-
quires positively selected thymocytes independently of their
engagement into the CD4+ or CD8+ lineage. The second pro-
cess, the generation of a normal number of mature mTECs within
a well-defined medulla, is critically dependent on thymocytes
committed to the CD4+ lineage. Our findings thus define an
unanticipated effector function of positively selected CD4+ thy-
mocytes. Furthermore, they identify a unique checkpoint in
thymic stromal development mediated by an antigen-specific
TCR-MHCII-mediated crosstalk between mTECs and CD4+
thymocytes.
It was recently proposed that RANKL-mediated signals deliv-
ered by LTi cells are implicated in the initial development of ma-
ture Aire+ mTECs during embryogenesis (Rossi et al., 2007).
However, subsequent reports indicated that the mechanisms
implicated in fostering mature mTEC development in the post-
natal thymus differ from those involved in the embryonic thymus.
First, whereas only RANK signaling is essential for mTEC devel-
opment during embryogenesis, cooperation between largely
nonredundant CD40 and RANK signals is required to establish
a normal medullary microenvironment in the postnatal thymus
(Akiyama et al., 2008). This is consistent with the finding that
the medullary defects in Tnfrsf11a/ and Cd40/ mice are
less severe than those exhibited by mice lacking TRAF6 or
NIK, which are key components of the intracellular signaling
pathways situated downstream of both RANK and CD40. Fur-
thermore, RANKL signals provided by LTi cells in the embryonic
thymus are replaced in the postnatal thymus by RANKL signals
supplied by positively selected thymocytes (Hikosaka et al.,
2008). RANKL produced by positively selected thymocytes is
critical for regulating mature mTEC cellularity in the postnatal
thymus by interacting with RANK and OPG expressed on
mTECs (Hikosaka et al., 2008). In contrast, other cellular sources
of RANKL, including LTi cells and gd T cells, are dispensable for
mature mTEC development in the adult thymus (Hikosaka et al.,
2008). These findings are fully compatible with our discovery
that CD4+ thymocytes play a prominent role in promoting mature
mTEC expansion, because both RANKL and CD40L are upregu-
lated preferentially by positively selected CD4+ thymocytes.
We report here that the role of CD4+ thymocytes in promoting
the expansion of mature mTEC cellularity is conferred, at least in
part, by their expression of CD40L and their ability todeliver a cos-
timulatory signal upon engagement of CD40 on mTECs. This is
consistent with the observation that the number of Aire+ cells is
reduced 2-fold in thymic sections from Cd40/ mice (White
et al., 2008). It is also coherent with the finding that strong over-Imexpression of a CD40L transgene in thymocytes led to expansion
of the medullary compartment, although this study did not specif-
ically address the role of CD40L in the development of mature
Aire+ mTECs (Dunn et al., 1997). Furthermore, the latter study
has to be interpreted with caution because several other severe
thymic defects were also observed in the CD40L transgenic mice.
The reductions in the number of mature mTEC observed in
Cd40lg/ and Cd40/ mice was less strong than those ob-
served in H2-Aa/, CiitaIV/IV, and CiitaIII+IV/III+IV mice. This
suggests that the CD40L-CD40 interaction does not constitute
the only critical signal delivered by CD4+ thymocytes. Other li-
gands that could contribute include LTa, LTb, LIGHT, and/or
RANKL, which are all expressed preferentially by CD4+ thymo-
cytes than CD8+ thymocytes. Our results thus identify CD4+
thymocytes as a common source of several potential signals im-
plicated in mature mTEC development. RANKL is a particularly
likely candidate, because its expression is—like CD40L’s—upre-
gulated preferentially by positively selected CD4+ thymocytes,
and it collaborates with CD40L in inducing the formation of a func-
tional medulla in the postnatal thymus (Akiyama et al., 2008).
Mature mTEC numbers were strongly reduced in Tg-
CiitaIII+IV/III+IV mice despite the development of a normal
CD4+ thymocyte population expressing WT amounts of
CD40L. Similarly, mature mTEC cellularity was strongly reduced
in OTII-Rag2/ mice despite the fact that their thymus con-
tained high numbers of positively selected CD4+ thymocytes
expressing WT levels of CD40L. These results imply that
CD40L-CD40 signaling can only drive mature mTEC expansion
if it is delivered in the context of antigen-specific TCR-MHCII-
mediated interactions between the CD4+ thymocytes and
mTECs. It is likely that efficient CD40L-CD40 signaling requires
that physical contacts between CD4+ thymocytes and mTEC
be stabilized and/or prolonged by antigen-specific TCR-MHCII
interactions. The cellular interaction we have uncovered is thus
analogous to the activation of antigen-presenting cells—such
as B cells, macrophages, and DCs—by T helper cells.
No change in the frequency of apoptotic mTEC was evident
in H2-Aa/ mice. On the other hand, there was a reduction in
the number of proliferating Ki-67+ cells in both the CD80 or lo
and CD80hi mTEC populations. Both populations have
been shown to contain proliferating cells, whereas mature
Aire+CD80hi mTECs are noncycling cells (Gray et al., 2007).
Our findings therefore suggest that the reduction in the number
of mature Aire+ mTECs observed in the absence of CD4+ thymo-
cytes is secondary to a defect in the proliferation of immature
CD80 or lo mTEC and/or AireCD80hi mTECs. Both possibilities
are compatible with a requirement for autoantigen-specific TCR-
MHCII-mediated interactions between CD4+ thymocytes and
mTECs. Indeed, although CD80hi mTECs clearly exhibit higher
levels of MHCII and express a wider range of TRAs, immature
mTECs already display low levels of MHCII and express a limited
number of TRAs (Kyewski and Klein, 2006). For instance, the
Aire-independent TRA myelin proteolipid protein (PLP) is ex-
pressed as strongly in immature mTECs as in mature mTECs
(data not shown) (Derbinski et al., 2005). It therefore remains to
be established whether the signals delivered by CD4+ thymo-
cytes promote the differentiation of mature Aire+ mTECs from
proliferating precursors in the immature CD80 or lo population,
the AireCD80hi population, or both.munity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc. 461
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Control of Mature mTEC Development by CD4+ T CellsOur results demonstrate that interactions between autoreac-
tive CD4+ thymocytes and mTECs displaying self-peptide-
MHC-II complexes play a pivotal role in controlling mature
mTEC cellularity in the postnatal thymus. Furthermore, our anal-
ysis of the RIPmOVA-OTII and Marilyn transgenic mouse models
indicates that there is a close correlation between the develop-
ment of a normal number of mature mTECs and ongoing nega-
tive selection of autoreactive CD4+ thymocytes. This suggests
that the two processes are tightly linked and could be mediated
by related cellular interactions. The thymic crosstalk process we
have uncovered may therefore be implicated in both the deletion
of autoreactive CD4+ thymocytes and the development of a ma-
ture mTEC population that is competent to ensure central toler-
ance. This feedback loop could form the basis of a dynamic
fine-tuning mechanism that allows the thymus to adapt its opti-
mal capacity for inducing negative selection to physiological,




Mice were on a C57BL/6 background, housed in a specific-pathogen-free fa-
cility, and sacrificed between 5 and 9 weeks of age. The K14-CIITA construct
contains a human CIITA cDNA inserted downstream of the human keratin 14
(K14) promoter in a modified version of the K14-hGH plasmid (provided by
Elaine Fuchs, Rockefeller University, New York, USA) (Vassar and Fuchs,
1991). This construct was injected into FVB/N embryos to yield a transgenic
line exhibiting constitutive MHCII expression on epidermal keratinocytes and
cTECs. The K14-CIITA transgene was backcrossed onto a C57BL/6 back-
ground and introduced into CiitaIV/IV and CiitaIII+IV/III+IV mice. Genotyping
is outlined in Supplemental Experimental Procedures. Experiments were ap-
proved by the Swiss federal and cantonal veterinary authorities.
Thymic Sections
Sections 10 mm thick were cut from frozen thymuses embedded in OCT
(Sakura Finetek), stained with hematoxylin and eosin, and used for immunoflu-
orescence analysis by standard procedures. Reagents used for staining of
sections are listed in Table S3. Sections were counterstained with 40,60-diami-
dino-2-phenylindole (DAPI) and mounted with Mowiol fluorescent mounting
medium (Calbiochem). Images were acquired with a Zeiss LSM 510 confocal
microscope. MTS10 fluorescence, Aire+ cells, and UEA-1+ cells were quanti-
fied with Metamorph and ImageJ software.
TEC Isolation
Thymic fragments were stirred gently in RPMI 1640 medium for 15 min at 4C
to remove free thymocytes and then transferred to fresh HBSS medium con-
taining 1 mg/ml collagenase D, 2 mg/ml DNaseI (Roche), incubated for 5 min
at 37C and subjected to vigorous pipetting. The last three steps were re-
peated thrice, discarding the supernatant each time. The DNaseI concentra-
tion was then increased to 10 mg/ml, and incubation was pursued until tissue
digestion was complete. Released cells were filtered to remove clumps.
Hematopoietic cells were depleted with anti-CD45 magnetic beads (Miltenyi
Biotec) by AutoMACS via the depleteS program.
Flow Cytometry
T cells, thymocytes, and TECs were analyzed by flow cytometry (FACScalibur,
Becton Dickinson) with standard procedures. Antibodies are listed in Table S3.
For intracellular Aire and Ki-67 staining, cells were fixed and stained with BD
Cytofix/Cytoperm and Perm/Wash buffers (Biosciences). Gating on mTECs
was performed by two well-established procedures (Figure S1) (Gray et al.,
2007; Rossi et al., 2007). A TdT-mediated dUTP nick-end labeling (TUNEL)
system was used according to the manufacturer’s instructions (Roche).462 Immunity 29, 451–463, September 19, 2008 ª2008 Elsevier Inc.Cell Sorting of Thymocytes
Thymocyte suspensions were incubated for 15 min at 4C with Fc-block (anti-
CD16/CD32, PharMingen) and incubated with anti-CD4 and anti-CD8 anti-
bodies, and DN, DP, and SP thymocytes were sorted with a FACSVantage
(Becton Dickinson). Anti-CD33 antibodies were used to isolate SP CD3+ cells.
Antibodies are listed in Table S3. Cell purity was between 80% and 90%.
Quantitative RT-PCR
Total RNA was prepared from CD45 thymic cells with TRIzol (Invitrogen).
cDNA was synthesized with random hexamers and Superscript II reverse tran-
scriptase (Invitrogen). PCR was performed with the iCycler iQ Real-Time PCR
Detection System and iQ SYBR green Supermix (Bio-Rad). Results were quan-
tified with a standard curve generated with serial dilutions of a reference cDNA.
GAPDH mRNA was used for normalization. Primer sequences are listed in
Table S4.
Reaggregated Thymus Organ Culture
Reaggregated thymus organ culture (RTOC) was performed as described
(Ueno et al., 2005). Thymic stromal cells were isolated from E15.5 fetal thymus
lobes cultured for 6 days in the presence of 2-deoxyguanosine and reaggre-
gated with equal numbers of DP thymocytes isolated from adult Tcra/
mice or CD4+ thymocytes isolated from adult WT mice. After 5 days in culture,
reaggregates were collected and analyzed by qRT-PCR.
Statistical Analysis
Statistical significance was assessed by the two-tailed Student’s t test.
SUPPLEMENTAL DATA
Supplemental Data include nine figures, four tables, Supplemental Experimen-
tal Procedures, and two movies and can be found with this article online at
http://www.immunity.com/cgi/content/full/29/3/451/DC1/.
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